Galmed Pharmaceuticals
GLMD
#10351
Rank
A$3.67 M
Marketcap
$2.22
Share price
-8.22%
Change (1 day)
-63.13%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2024 (TTM): -A$9.36 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$11.44 Million, an increase over its 2022 earnings that were of -A$29.56 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$9.36 Million-18.18%
2023 -A$11.44 Million-61.31%
2022 -A$29.56 Million-44.97%
2021 -A$53.71 Million12.85%
2020 -A$47.59 Million40.61%
2019 -A$33.85 Million109.19%
2018 -A$16.18 Million-20.47%
2017 -A$20.35 Million-27%
2016 -A$27.87 Million58.6%
2015 -A$17.57 Million16.7%
2014 -A$15.06 Million-47.94%
2013 -A$28.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.16 Billion 1,338.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.96 Billion 37,722.90%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-A$38.45 Million 267.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.03 Million-23.30%๐Ÿ‡บ๐Ÿ‡ธ USA